# MRONJ and Polynucleotides-Hyaluronic Acid Hydrogel (Regenfast®)

> **NCT06984107** · NA · NOT_YET_RECRUITING · sponsor: **Fondazione Policlinico Universitario Agostino Gemelli IRCCS** · enrollment: 10 (estimated)

## Conditions studied

- Medication Related Osteonecrosis of the Jaw

## Interventions

- **DEVICE:** MRONJ resection plus PN+HA

## Key facts

- **NCT ID:** NCT06984107
- **Lead sponsor:** Fondazione Policlinico Universitario Agostino Gemelli IRCCS
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2025-09-01
- **Primary completion:** 2026-09-01
- **Final completion:** 2027-03-01
- **Target enrollment:** 10 (ESTIMATED)
- **Last updated:** 2025-05-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06984107

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06984107, "MRONJ and Polynucleotides-Hyaluronic Acid Hydrogel (Regenfast®)". Retrieved via AI Analytics 2026-05-29 from https://api.ai-analytics.org/clinical/NCT06984107. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*